Navigation Links
Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes'
Date:4/30/2009

Register for an Educational Webinar "How Organizations Can Make the Transition to SPL R4 Compliance," Hosted by Pilgrim Software and featuring Virtify, Inc.

CAMBRIDGE, Mass., April 30 /PRNewswire/ -- Virtify, Inc. (www.virtify.com), the market leader in Enterprise Content Compliance solutions for life sciences, and Pilgrim Software (www.pilgrimsoftware.com), a provider of Enterprise Compliance and Quality Management (ECQM) software solutions, will host a complimentary Webinar on best practices in SPL R4 compliance and how organizations can make the necessary transitions required by the new June 2009 mandate. The Webinar will take place on Thursday, May 7th at 11:00 a.m. EDT and feature Dr. Satish Tadikonda, founder and president of Virtify, Inc. This Webinar is for all human health, animal health, biologics and vaccines organizations and medical device companies who are modifying in-house systems or evaluating new technologies to meet the new SPL R4 requirements. The webinar is designed as a "how to" primer on complying with SPL R4.

Attendees will learn about:

  • Best practices for complying with SPL R4
  • Accelerating the conversion process from SPL R3 submissions to SPL R4 submissions
  • Automating the information transfer to SPL XML structure
  • Managing the changes involved with SPL R4 and streamlining submissions planning, preparation and tracking
  • Performing in-depth validation and QC for SPL R4 information

Title: "Best Practices for SPL R4 Compliance for Life Sciences Companies - Are You Ready for the June 2009 Mandate?"

Presenter: Dr. Satish Tadikonda, founder and president, Virtify, Inc.

Date/Time: Thursday, May 7 at 11:00 am EDT

To
'/>"/>

SOURCE Virtify, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
2. CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
3. Intercell Announces European Approval of New Vaccine, IXIARO(R), to Prevent Japanese Encephalitis
4. Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis
5. Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
6. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
7. IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its Embracing Human Technology Interactions Media Event
8. The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment
9. Ecologists propose first prevention for white-nose syndrome death in bats
10. White Paper Details How DNA Sequencing Services Can Prevent Cleanroom Shutdowns at Medical Device and Pharmaceutical Manufacturers
11. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... CAMBRIDGE, Mass. , July 30, 2015 /PRNewswire/ ... software solutions for the interpretation and analysis of ... Matthew Fischer has joined the company ... Photo - http://photos.prnewswire.com/prnh/20150730/250931 ... astounding capabilities to integrate, interpret, analyze and explore ...
(Date:7/30/2015)... -- According to a new market research ... PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), by ... End Users - Global Forecast to 2020", published by ... 2,107.99 million by 2020 from USD 1,034.93 million in ... Browse more than 75 market ...
(Date:7/30/2015)... SAN DIEGO, July 30, 2015   Senomyx , ... proprietary taste science technologies to discover, develop, and commercialize ... supply industries, today reported financial results for the second ... half of 2015, we remain on track to achieve ... and Chief Executive Officer of the Company. "Since our ...
(Date:7/30/2015)... -- HIGHLIGHTS:Q2 2015 Results (all changes are ... sales were $697 million compared to $701 million in ... 8%, and changes in foreign currency exchange rates decreased ... , By business unit, organic sales growth was ... SAFC Commercial. , Reported diluted EPS was $0.98 ...
Breaking Biology Technology:GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... also available in German . , The ... molecules, which start as random mixtures, demonstrates a fundamental ... activated by instructions which are built-in to the molecules. ... positions move to make room for others which fit ...
... at 5:00 p.m. Eastern Time, THE WOODLANDS, ... LXRX ), a biopharmaceutical company focused,on discovering and ... results for the three and nine months ended,September ... in our 10to10 initiative in the third,quarter, completing ...
... CHICAGO, Oct. 30 Advanced Life Sciences,Holdings, Inc. ... will present at the,Acumen BioFin Rodman & Renshaw ... will be webcast live via streaming audio. Advanced ... of the Company,s,business. (Logo: http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO ) ...
Cached Biology Technology:Evolution in the nanoworld 2Evolution in the nanoworld 3Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results 2Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results 3Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results 4Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results 5Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results 6Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results 7Advanced Life Sciences to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2
(Date:7/7/2015)... 2015 Research and ... of the "Capacitive Fingerprint Sensors Patent Landscape" ... this date, fingerprint sensing technology is the most ... are well developed. This patent landscape focuses on ... The domain of capacitive fingerprint sensors is closely ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ) has ... Market by Application, Technology, Function & Geography - Global ... The next generation biometrics market is expected to ... 17.9% between 2015 and 2020 Travel & ... Safran SA ( France ), NEC ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Latin America Biomedical Sensors Market Report 2015-2020 2
... comb jellyfish can sneak up on its prey like ... Researchers, including one from the University of Gothenburg, have ... itself hydrodynamically ,invisible,. The North American comb jellyfish ... consume vast quantities of zooplankton. A few years ago ...
... from the Slone Epidemiology Center at Boston University School ... who consume more vegetables are less likely to develop ... intake. The study results, published in the American ... the Black Women,s Health Study (BWHS), a large follow-up ...
... it comes to gambling, many people rely on game theory, ... choices of others to inform their own decisions. It,s used ... But recent findings from a Tel Aviv University researcher suggest ... we look to bacteria instead. According to Prof. ...
Cached Biology News:Voracious comb jellyfish 'invisible' to prey 2Consuming vegetables linked to decreased breast cancer risk in African-American women 2Gambling on bacteria 2Gambling on bacteria 3
...
... TAMRA isomers are predominantly used for labeling ... for labeling peptides and nucleotides because they ... is often required in the conjugation processes. ... for labeling peptides and proteins. 6-TAMRA is ...
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
Alkali soluble casein is the recommended blot blocking reagent for use with the HisTag Monoclonal Antibody (Novagen) on Western blots....
Biology Products: